Amylyx prices newly approved ALS drug at $158,000 per year

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. SPY
2. META
3. PATH
4. KBH
5. USO
6. AZO
7. QQQ
8. ORCL
9. RCL
10. ONON

Go back to Amylyx prices newly approved ALS drug at $158,000 per year
(NASDAQ: AMLX) Delayed: 30.61 --0 (-0%)
Previous Close $30.61    52 Week High $ 
Open $30.61    52 Week Low $ 
Day High $30.61    P/E N/A 
Day Low $30.61    EPS $ 
Volume 4